Final results from a Phase 3, long-term, open-label, repeat-dose safety study of diazepam nasal spray for seizure clusters in patients with epilepsy

for the DIAZ.001.05 Study Group

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Final results from a Phase 3, long-term, open-label, repeat-dose safety study of diazepam nasal spray for seizure clusters in patients with epilepsy'. Together they form a unique fingerprint.

Medicine & Life Sciences